SEI INVESTMENTS CO - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$844,283
-87.7%
73,609
-72.8%
0.00%
-83.3%
Q2 2023$6,861,059
-25.6%
271,079
-5.3%
0.01%
-29.4%
Q1 2023$9,216,956
+190.5%
286,151
+66.5%
0.02%
+142.9%
Q4 2022$3,172,446
-24.5%
171,855
+10.5%
0.01%
-22.2%
Q3 2022$4,201,000
+319.7%
155,567
+113.2%
0.01%
+350.0%
Q2 2022$1,001,000
-26.9%
72,977
+3.8%
0.00%
-33.3%
Q1 2022$1,369,000
+15.3%
70,281
-3.6%
0.00%
+50.0%
Q4 2021$1,187,000
-41.4%
72,927
+0.3%
0.00%
-50.0%
Q3 2021$2,027,000
-10.3%
72,703
-4.6%
0.00%
-20.0%
Q2 2021$2,260,000
-5.8%
76,225
-11.0%
0.01%
-16.7%
Q1 2021$2,398,000
-9.9%
85,642
-8.7%
0.01%
-14.3%
Q4 2020$2,662,000
-2.8%
93,820
-13.8%
0.01%
-12.5%
Q3 2020$2,739,000
+5.8%
108,841
+2.7%
0.01%0.0%
Q2 2020$2,590,000
+64.8%
106,024
-0.4%
0.01%
+33.3%
Q1 2020$1,572,000
-13.0%
106,431
-4.5%
0.01%
+20.0%
Q4 2019$1,806,000111,4510.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders